Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03331380 · ClinicalTrials.gov registry record · NA
Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System
A NA study of CAD, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Recruiting
- Registry status
- NA
- Development phase
- 2,950
- Enrollment target
- 1
- Study location
NCT03331380 is a NA study of CAD that is actively recruiting participants, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 2,950 participants, above the 1,308-participant average among 4 other CAD trials with a reported enrollment target (126% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03331380, a NA study of CAD, is actively recruiting participants, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- RECRUITING
- Registry status
- NA
- Development phase
- 2,950 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Researchers are testing version of a system known as a magnetic resonance imagining (MRI) scanner that uses strong magnetic fields, radio waves and the like to create images of the organs in the body. It uses lower energy levels than other MRI scanners. This may help scan people with metal devices in their body, or in invasive heart procedures using metal tools. Objective: To test a new MRI scanner and software changes to create better pictures. Eligibility: People with disease and healthy volunteers, ages 18 and older. Design: Participants will be screened with blood tests. Participants may have both the new MRI and a conventional MRI or only the new one. If 2 are done, they must be within 60 days. For both MRI versions, participants lie on a table that slides into a large tube. During scans, they will hold their breath for up to 20 seconds at a time. Heart activity will be measured by wires connected to pads on the skin. A flexible belt may be used to monitor their breathing. They will be in the scanner up to 2 hours. Participants can agree to have a dye called gadolinium injected into their arm during the scan. This brightens the pictures. Participants can agree to take a drug called a vasodilator. This helps detect areas of the heart with abnormal blood supply. Scans of the heart are taken before, during, and after they get the medicine. The drug may cause temporary chest pain or shortness of breath. They may get other drugs to relieve these symptoms. Sponsoring Institution: National Heart, Lung, and Blood Institute
Conditions Studied
Interventions
- DEVICE MRI scan - obj 1
- DEVICE MRI scans - obj 2
- DEVICE MRI scans - obj 3
- DEVICE MRI scans - obj 4
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,950 participants |
| Start Date | 2018-01-05 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03331380
The ClinicalTrials.gov registry entry for NCT03331380 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,950 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,308-participant average among 4 other CAD trials with a reported enrollment target (126% higher). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with CAD appearing as the primary indexed condition, and to 4 interventions - of which MRI scan - obj 1 is the first listed.
NCT03331380 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03331380 about?
NCT03331380 is a clinical study titled "Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System". Background: Researchers are testing version of a system known as a magnetic resonance imagining (MRI) scanner that uses strong magnetic fields, radio waves and the like to create images of the organs in the body. It uses lower energy levels than other MRI scanners. This may help scan people with me...
What is the current status of trial NCT03331380?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,950 participants. The study started on 2018-01-05. Estimated completion is 2026-05-31.
What conditions does trial NCT03331380 study?
This clinical trial studies the following conditions: CAD.
What interventions are being tested in trial NCT03331380?
The interventions under investigation include: MRI scan - obj 1 (DEVICE), MRI scans - obj 2 (DEVICE), MRI scans - obj 3 (DEVICE), MRI scans - obj 4 (DEVICE).
Who is sponsoring clinical trial NCT03331380?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03331380 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for CAD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Coronary Orbital Atherectomy System Study
COMPLETED · NA
-
Comprehensive Computed Tomography Guidance of Coronary Bypass Graft Surgery
RECRUITING
-
Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree
COMPLETED
-
Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES)
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.